| Literature DB >> 25666236 |
Behzad Pourhossein1,2, Amin Doosti Irani1,3, Ehsan Mostafavi1,4.
Abstract
OBJECTIVES: As Afghans make up the largest group of foreign nationals in Iran, the aim of this study was to assess the proportion of Afghan immigrants among those afflicted by the most prevalent infectious diseases in Iran.Entities:
Keywords: Afghan; Health; Immigrant; Infection; Iran; Systematic review
Year: 2015 PMID: 25666236 PMCID: PMC4371390 DOI: 10.4178/epih/e2015002
Source DB: PubMed Journal: Epidemiol Health ISSN: 2092-7193
Figure 1.Flow diagram showing the phases of retrieving articles, checking eligibility criteria, and including the articles into the meta-analysis.
Characteristics of the included studies in meta-analysis
| Author (published year) [Ref] | Location | Type of the disease | Sex | Sample size | Afghan patients (%) | Iranian patients (%) |
|---|---|---|---|---|---|---|
| Abbasi et al. (2004) [ | Gorgan | Leishmaniasis | M, F | 175 | 2.29 | 97.71 |
| Alavi-Naini et al. (2006) [ | Zabol & Zahedan | CCHF | M, F | 255 | 25.5 | 74.5 |
| Aminzadeh & Akhyani (2005) [ | Tehran | Tuberculosis | M, F | 81 | 17.28 | 82.72 |
| Amirmozafari et al. (2006) [ | Tehran | Tuberculosis | M, F | 439 | 21.18 | 78.82 |
| Ayatollahi et al. (2010) [ | Yazd | Tuberculosis | M, F | 32 | 21.88 | 78.12 |
| Ayatollahi et al. (2010) [ | Shiraz | Tuberculosis | M, F | 104 | 45.2 | 54.8 |
| Barati et al. (2010) [ | Karaj | Cholera | M, F | 54 | 7.4 | 92.6 |
| Doroudchi et al. (2000) [ | Shiraz | Tuberculosis | M, F | 101 | 20.79 | 79.2 |
| Ebrahimzadeh et al. (2009) [ | Birjand | Tuberculosis | M, F | 840 | 3.93 | 96.07 |
| Farnia et al. (2006) [ | Tehran | MDR TB | M, F | 263 | 66.54 | 33.46 |
| Farnia et al. (2006) [ | Tehran | Tuberculosis | M, F | 1479 | 33.34 | 66.66 |
| Faenia et al. (2008) [ | Tehran | Tuberculosis | M, F | 199 | 22.61 | 77.39 |
| Fathimoghaddam et al. (2011) [ | Mashhad | Hepatitis B | M, F | 22 | 13.64 | 86.36 |
| Forotani (2007) [ | Larestan | Malaria | M, F | 80 | 33.75 | 66.25 |
| Izadi et al. (2004) [ | Zahedan & Zabol | CCHF | M, F | 24 | 20.8 | 79.2 |
| Jonaidi et al. (2007) [ | National | Cholera | M, F | 1115 | 2.24 | 97.76 |
| Kadivar et al. (2007) [ | Shiraz | Tuberculosis | M, F | 1026 | 36.16 | 63.84 |
| Khalifesoltani et al. (1997) [ | Kashan | Tuberculosis | M, F | 183 | 32.79 | 67.21 |
| Khatami et al. (2008) [ | Tehran | Tuberculosis | M, F | 30 | 36.67 | 63.33 |
| Khazaei et al. (2005) [ | Zabol | Cholera | M, F | 362 | 18.78 | 81.22 |
| Khazaei et al. (2005) [ | Zabol | Tuberculosis | M, F | 2731 | 23.51 | 76.49 |
| Mansoori et al. (2003) [ | National | Tuberculosis | M | 373 | 31.5 | 68.49 |
| Mohammadi Anzi et al. (2008) [ | Damghan | Tuberculosis | M, F | 89 | 222.47 | 77.53 |
| Mohammadi Anzi et al. (2010) [ | Damghan | Leishmaniasis | M, F | 465 | 4.3 | 95.7 |
| Momeni & Aminjavaheri (1994) [ | Isfahan | Leishmaniasis | M, F | 1250 | 13.2 | 86.8 |
| Moshfe et al. (2003) [ | Kohgiluyeh & Boyer-Ahmad | Malaria | M, F | 485 | 37.32 | 62.68 |
| Mousavi et al. (2009) [ | Kashan | Tuberculosis | M, F | 196 | 54.59 | 45.81 |
| Najafi et al. (2006) [ | Mazandaran | Malaria | M, F | 518 | 80.31 | 19.69 |
| Raeisi et al. (2009) [ | National 2002 | Malaria | M, F | 15378 | 42.13 | 57.87 |
| Raeisi et al. (2009) [ | National 2003 | Malaria | M, F | 25027 | 21.9 | 78.1 |
| Raeisi et al. (2009) [ | National 2004 | Malaria | M, F | 13166 | 30.49 | 69.51 |
| Raeisi et al. (2009) [ | National 2005 | Malaria | M, F | 19285 | 13.5 | 86.5 |
| Raeisi et al. (2009) [ | National 2006 | Malaria | M, F | 15896 | 10.39 | 89.61 |
| Raeisi et al. (2009) [ | National 2007 | Malaria | M, F | 16647 | 7.45 | 92.55 |
| Ramazanzadeh et al. (2006) [ | National | Tuberculosis | M, F | 345 | 25.22 | 74.78 |
| Ranjbar et al. (2010) [ | Karaj | Cholera | M, F | 110 | 4.55 | 95.45 |
| Salarri & Kalantari (2004) [ | Yazd | Tuberculosis | M, F | 600 | 36.34 | 63.66 |
| Salehi & Pourahmad (2001) [ | Isfahan | Tuberculosis | M, F | 164 | 45.12 | 54.88 |
| Setoudeh Maram & Fararoei (1999) [ | Fars | Tuberculosis | M, F | 977 | 13.2 | 86.79 |
| Shamaei et al. (2009) [ | National | Tuberculosis | M, F | 548 | 33.94 | 66.06 |
| Sharifi-Mood (2006) [ | Zahedan | Tuberculosis | M, F | 195 | 16.92 | 83.08 |
| Soleimanifard et al. (2011) [ | Isfahan | Malaria | M, F | 675 | 97.92 | 3.55 |
| Tajadin et al. (2008) [ | Tehran | Tuberculosis | M, F | 191 | 38.22 | 61.78 |
| Velayati et al. (2009) [ | National | MDR TB | M, F | 146 | 44.52 | 55.47 |
| Yazdanpanah et al. (2003) [ | Tehran | Tuberculosis | F | 481 | 27.65 | 72.35 |
| Yazdanpanah et al. (2003) [ | Tehran | Tuberculosis | M | 547 | 35.28 | 64.72 |
| Youssefi & Taghi (2011) [ | Sistan & Baluchestan | Malaria | M, F | 1461 | 3.35 | 82.68 |
| Zia-Sheikholeslami & Rezaeian (2010) [ | Rafsanjan | Malaria | M, F | 742 | 98.92 | 1.08 |
Ref, reference; CCHF, Crimean-Congo hemorrhagic fever; MDR TB, multiple-drug-resistant tuberculosis; M, male; F, female.
Subgroup analysis of proportion of Afghan immigrant population with infectious diseases by quality of the included studies, year of studies conduction and type of infectious diseases
| Afghan immigrants | p-value | ||
|---|---|---|---|
| Proportion | 95% CI | ||
| Quality of included studies | |||
| Low risk | 0.206 | 0.146, 0.267 | 0.001 |
| Intermediate | 0.305 | 0.218, 0.392 | 0.001 |
| High risk | 0.354 | 0.108, 0.601 | 0.001 |
| Year of study conduction | |||
| 1994-2000 | 0.118 | 0.132, 0.244 | 0.001 |
| 2000-2007 | 0.307 | 0.221, 0.393 | 0.001 |
| 2007-2011 | 0.277 | 0.053, 0.607 | 0.001 |
| Type of diseases | |||
| Tuberculosis | 0.288 | 0.233, 0.344 | 0.001 |
| MDR TB | 0.557 | 0.341, 0.773 | 0.001 |
| Malaria | 0.398 | 0.230, 0.566 | 0.001 |
| Cholera | 0.082 | 0.004, 0.159 | 0.001 |
| Crimean Congo Hemorrhagic fever | 0.25 | 0.200, 0.301 | 0.59 |
| Leishmaniasis | 0.066 | 0.000, 0.132 | 0.001 |
CI, confidence interval; MDR TB, multiple-drug-resistant tuberculosis.
p-value for chi square test for heterogeneity.